SEIDENBERG BETH C

SEC Form 4 insider trading activity

SEIDENBERG BETH C has filed 3 SEC Form 4 filings (9 transaction rows) across 2 companies, including LTGO, KYTX, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Aug 11, 2026.

On the most recent filing, SEIDENBERG BETH C is listed as Director at Kyverna Therapeutics, Inc. Inside the rolling window, SEIDENBERG BETH C reported 1 open-market purchase totaling $1000K in KYTX and no open-market sales.

Companies traded

Other insiders at LTGO

Insider Buying

$1000K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

2

in the rolling window

Source
KYTX
SEIDENBERG BETH C
Purchase$1000KDec 22SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has SEIDENBERG BETH C made?

SEIDENBERG BETH C has filed 3 SEC Form 4 filings (9 transaction rows) across 2 companies, including LTGO, KYTX since 2025.

Which companies does SEIDENBERG BETH C trade?

SEIDENBERG BETH C has filed SEC Form 4 disclosures for 2 companies, including LTGO, KYTX.

When was SEIDENBERG BETH C's most recent SEC Form 4 filing?

SEIDENBERG BETH C's most recent SEC Form 4 filing on Tracefour is dated Aug 11, 2026.

What is SEIDENBERG BETH C's total buy and sell value in the current window?

Inside the rolling retention window, SEIDENBERG BETH C bought $1000K and sold $0 based on SEC Form 4 filings.

What was SEIDENBERG BETH C's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 133,333 KYTX shares on 2025-12-18, worth $1000K, per SEC Form 4 filings.